Vaccines for adults: a review of recent literature

Mahir Ahmed, Bayan Alorinan, Abdullah AlYemni, Mohammed Albakri, Mohamme Alahmari, Ayan Hassan, Abdulaziz Alrahili, Abdullah Alfawzan, Abdulrahman Alazzouni, Abdulaziz Alansari


Vaccinations in adults and older patients are of special importance due to two main reasons: physiological and anatomical alterations in the body as it ages, making diseases more serious and possibly fatal, and so that adult individuals have a decreased immunological response when they are exposed to infections. Major adult vaccination includes influenza, pneumococcal pneumonia and meningitis, pertussis, tetanus, diphtheria, and hepatitis. In this study, our aim was to understand the recent updates on adult immunization and their efficacy in disease prevention. We conducted this review using a comprehensive search of MEDLINE, PubMed and EMBASE from January 1994 to March 2017. The following search terms were used: adult vaccination, adult immunization, influenza, pneumococcal pneumonia and meningitis, pertussis, tetanus, diphtheria, preventive measures, infection prevention. Several communicable diseases that affect the elderly population which can cause significant morbidity and mortality along with excessive costs on the health care system are easily preventable with the use of vaccination. Therefore, using vaccines to prevent these diseases should be updated and encouraged by all family health care practices.


Adult immunization, Adult vaccination, Preventive health measures

Full Text:



National Vaccine Advisory Committee. A pathway to leadership for adult immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on June 14, 2011. Public Health Rep. 2012;127:1–42.

Kale SS, Ahuja N, Yende S. The epidemiology of aging. In: Newman AB, Cauley JA, eds. Dordecht (Netherlands): Springer; 2012: 237–253.

Taub DD, Longo DL. Insights into thymic aging and regeneration. Immunol Rev. 2005;205:72–93.

Castle SC, Uyemura K, Fulop T, Makinodan T. Host resistance and immune responses in advanced age. Clin Geriatr Med. 2007;23(3):463–79.

Healthy people 2020. Immunization and Infectious Diseases. Available at: https://www.healthypeople. gov/2020/topicsobjectives/ topic/immunization-and-infectious-diseases. Accessed on 3 June 2018.

Williams WW, Lu PJ, O’Halloran A, Kim DK, Grohskopf LA, Pilishvili T, et al. Surveillance of vaccination coverage among adult populations—United States, 2015. MMWR Surveill Summ. 2017;66(11):1–28.

McLaughlin JM, McGinnis JJ, Tan L, Mercatante A, Fortuna J, et al. Estimated human and economic burden of four major adult vaccine-preventable diseases in the United States, 2013. J Prim Prev. 2015;36(4):259–73.

Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351:2611–8.

Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med. 2003;348:1322–32.

Phrommintikul A, Kuanprasert S, Wongcharoen W, Kanjanavanit R, Chaiwarith R, Sukonthasarn A. Influenza vaccination reduces cardiovascular events in patients with acute coronary syndrome. Eur Heart J. 2011;32:1730–5.

Jefferson T, Di Pietrantonj C, Al-Ansary LA, Ferroni E, Thorning S, Thomas RE. Vaccines for preventing influenza in the elderly. Cochrane Database Syst Rev. 2019;17(2):CD004876.

DiazGranados CA, Dunning AJ, Kimmel M, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med. 2014;371:635–45.

Nace DA, Len CJ, Ross TM, Saracco S, Churilla RM, Zimmerman RK. Randomized, controlled trial of high-dose influenza vaccine among frail residents of long-term care facilities. J Infect Dis. 2015;211:1915–24.

FLUAD. Novartis Vaccines and Diagnostics, Inc. Cambridge, MA. Available at: https://flu.seqirus. com/files/us%20package%20insert_fluad%202015-2016.pdf. 2015. Accessed on 18 September 2015.

Centers for Disease Control and Prevention. Influenza (flu). Available at: protect/vaccine/vaccines.htm. Accessed on 18 September 2015.

Osterholm MT, Kelley NS, Sommer A, Belongia EA. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:36–44.

Grohskopf LA, Sokolow LZ, Olsen SJ, Broder KR, Walter EB. Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices. Morb Mortal Wkly Rep. 2015;64:818–25.

Griffin MR. Influenza vaccination of healthcare workers: making the grade for action. Clin Infect Dis. 2014;58:58–60.

Potter J, Stott DJ, Roberts MA, Elder AG, O'Donnell B, Knight PV, et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis. 1997;175:1–6.

National Vaccine Advisory Committee. Strategies to achieve the Healthy People 2020 annual influenza vaccine coverage goal for health-care personnel: recommendations from the National Vaccine Advisory Committee. Public Health Rep. 2013;128:7–25.

World Health Organization. 23-valent pneumococcal polysaccharide vaccine: WHO position paper. Wkly Epidemiol Rec. 2008;83:373–84.

Curcio D, Cane A, Isturiz R. Redefining risk categories for pneumococcal disease in adults: critical analysis of the evidence. Int J Infect Dis. 2015;37:30–5.

Moberley S, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2013;31(1):CD000422.

Musher DM. Editorial commentary: should 13-valent protein-conjugate pneumococcal vaccine be used routinely in adults? Clin Infect Dis. 2012;55:265–7.

Williams WW, Lu PJ, O’Halloran A, Bridges CB, Kim DK, Pilishvili T, et al. Vaccination coverage among adults, excluding influenza vaccination – United States, 2013. Morb Mortal Wkly Rep. 2015;64:95–102.

Pletz MW, Maus U, Krug N, Welte T, Lode H. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species. Int J Antimicrob Agents. 2008;32:199–206.

Moore MR, Link-Gelles R, Schaffner W, Lynfield R4, Lexau C4, Bennett NM, et al. Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis. 2015;15(3):301-9.

Centers for Disease Control and Prevention. Adult immunization schedules. United States. Available at: adult.html. Accessed on 15 September 2018.

McQuillan GM, Kruszon-Moran D, Deforest A, Chu SY, Wharton M. Serologic immunity to diphtheria and tetanus in the United States. Ann Intern Med. 2002;136:660–6.

Centers for Disease Control and Prevention. Pertussis (whooping cough) surveillance and reporting. Available at: pertussis/surv-reporting. html. Accessed on October 19, 2018.